4/6/26 - sorry for the wait!

The podcast centers on pharmaceutical stocks, peptide use, and investment strategies, with Martin Shkreli and others analyzing various companies and market trends. Discussions include Celeno's acquisition by Neurocrin, Lightwave Logic's photonic devices, and Amgen's Repath, alongside commentary on Cristexa's revenue growth. The hosts delve into the potential of Viking Therapeutics (VKTX) and Vaxcite, assessing their market positions and future prospects. A significant portion of the conversation addresses the use of peptides, with the hosts sharing personal experiences and opinions, while also touching on the risks and benefits. Additionally, the podcast explores the potential of optical computing and QCLS, estimating timelines for their commercial viability and impact on GPU technology.